Healthcare & Medical

World Orphan Drug Congress 2026

This edition has ended

World Orphan Drug Congress 2026 ran Oct 26–28, 2026 at RAI Amsterdam Convention Centre in Amsterdam, Netherlands. It is a Healthcare & Medical conference. ConferenceGrid lists 88 speakers, 34 sponsors, 1 exhibitor and 19 sessions. Dates for the next edition are not announced yet.

Lineup updated Oct 28, 2026 · dates verified Aug 16, 2026

The World Orphan Drug Congress 2026 brings together leaders in strategy, advocacy, and partnering from the orphan drug industry. It serves as a forum for industry professionals, regulators, patients, and other stakeholders to discuss the latest trends, innovations, and challenges in the orphan drug field.

Visit the official siteRegister
88Speakers
34Sponsors
1Exhibitors
19Sessions
107Companies · in total

Speakers

Spoke at the 2026 edition, which has ended. In alphabetical order.

Adam Bloomfield
Vice President Medical Affairs · Premier Research
Adrian Haigh
Senior Vice President and General Manager Emea and Asia Pacific Region · PTC Therapeutics
Alessandra Ferlini
Director of the Medical Genetics Section & Unit · University of Ferrara
Alessio Amadasi
Vice President, Medical Affairs EU/International, Rare Diseases · Chiesi Farmaceutici Spa
Alexander Natz
Secretary General · EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Alexion Pharma Netherlands B.V.
Alexion Pharma Netherlands B.V.
Alexis Arzimanoglou
Coordinator of the European Reference Network for Rare and Complex Epilepsies · EpiCARE
Alicia Be
Senior Account Manager · FIPRA International
Alicia Granados
Global Head Scientific Advocacy and Insights · Sanofi
Amanda Bok
Chief Partnerships Officer · The Synergist
Andrea Ballerini
Medical Director · Italfarmaco
Anjan Aralihalli
President & Founder · Raya Therapeutic, Inc.
Anna Bucsics
Project Advisor · MoCA
Annemieke Aartsma Rus
Professor Of Translational Genetics, Department Of Human Genetics · Leiden University Medical Center (Netherlands)
Annette Bakker
CEO · Childrens Tumor Foundation
Aurora Berra
Global Patient Officer · Ipsen
Bos
Board Member · SMA Europe
Bruno Sarfati
CEO · Tekkare
Calie Sharman
Vice President Global Value & Access, Rare Diseases · Ipsen
Daria Julkowska
Head of Strategy & Partnerships in Health · ERDERA - INSERM
Dariusz Adamczewski
Managing Director · Children’s Tumor Foundation Europe
David Allison
Chief Executive Officer · TREAT-NMD

Sponsors

Sponsored the 2026 edition, which has ended. Tiers as disclosed.

Alliance for Regenerative MedicineSupporting Partner
Americas Health FoundationSupporting Partner
AsebioSupporting Partner
Becaris PublishingSupporting Partner
BIOCATSupporting Partner
BioInsightsSupporting Partner
Biopharma AsiaSupporting Partner
Check RareSupporting Partner
EATRISSupporting Partner
Endo ERNSupporting Partner
EpiCARESupporting Partner
ERDERASupporting Partner & Exhibitor
ERN BONDSupporting Partner
ERN eUROGENSupporting Partner
EuropaBioSupporting Partner
FH Europe Foundation NGOSupporting Partner & Exhibitor
Gene Therapy NetSupporting Partner
HealthEconomics.comSupporting Partner
Health-HollandSupporting Partner
hollandbioSupporting Partner
IRDiRCSupporting Partner
LMNA CardiacSupporting Partner
Market Access TodaySupporting Partner
MarketsandMarketsSupporting Partner
National Pharmaceutical CouncilSupporting Partner
NAVLIN Daily by EversanaSupporting Partner
Pathways To TrustSupporting Partner & Exhibitor
Patient WorthySupporting Partner
Rare Disease 360Supporting Partner
RARE RevolutionSupporting Partner & Exhibitor
SCREEN4CARESupporting Partner
touchENDOCRINOLOGYSupporting Partner
touchHAEMATOLOGYSupporting Partner
touchOPHTHAMOLOGYSupporting Partner

Agenda

The 2026 program, selected from 19 sessions.

  • Oct 26 10:00

    Building a unified voice in Rare Diseases: Lessons from the Rare Liver Community

    People affected by rare liver diseases face recurring challenges across diagnosis, specialist care, evidence generation and access. Yet action is often organised disease by disease…

    Ipsen Workshop
  • Oct 26 11:30

    ERDERA: AI for Rare Diseases: From Promise to Practice

    Artificial intelligence is rapidly becoming an integral part of the rare disease ecosystem, supporting scientific discovery, therapeutic development and strategic decision-making. …

    Workshop - ERDERA
  • Oct 26 14:00

    Early Diagnosis – What’s Needed to Make Change Happen?

    Moving beyond isolated advocacy to accelerate diagnosis, this workshop will holistically explore how early diagnosis fits within the rare disease ecosystem from development of diag…

    Sanofi Workshop
  • Oct 26 14:00

    HTAi: Implementing HTA recommendations, Evidence assessment, economic modelling, and how legislation drives HTA change

    HTAi Workshop
  • Oct 26 15:30

    From EU Approval to Patient Availability: Rethinking the Path for Orphan Drugs in The Netherlands

    A medicine may be approved in Europe and still remain out of reach for patients in the Netherlands. Why? Three patient organisations will bring the access challenge to life throug…

    Alexion Workshop
  • Oct 26 15:30

    How can we improve access to orphan drugs in the Netherlands? - Title TBC

    - The need for a separate approval pathway for Orphan Drugs - How will new Reimbursement models help Pharmaceutical companies navigate Orphan Drug development?

    Alexion Workshop
  • Oct 26 17:00

    A Rare Networking Opportunity - Offsite Networking Drinks

    A Rare Networking Opportunity brings together rare disease patient advocates and professionals working towards rare disease therapies - not to pitch or present, but to genuinely co…

    Alexion Workshop
  • Oct 26 17:30

    A Rare Networking Opportunity - Offsite Networking Drinks

    A Rare Networking Opportunity brings together rare disease patient advocates and professionals working towards rare disease therapies - not to pitch or present, but to genuinely co…

    Networking
  • Oct 27 10:00

    Keynote Panel: The next frontier in rare disease, where will the breakthroughs come from?

    - What’s in the pipeline and what rare diseases have been targeted? - How have global launch strategies been impacted by MFN? - Emerging platforms (gene, cell, RNA etc) and novel t…

    Keynotes

Quick answers

When is World Orphan Drug Congress 2026?
World Orphan Drug Congress 2026 ran Oct 26–28, 2026 at RAI Amsterdam Convention Centre in Amsterdam, Netherlands.
Where is World Orphan Drug Congress 2026 held?
World Orphan Drug Congress 2026 was held at RAI Amsterdam Convention Centre in Amsterdam, Netherlands.
Who is speaking at World Orphan Drug Congress 2026?
ConferenceGrid lists 88 speakers, including Adam Bloomfield (Vice President Medical Affairs, Premier Research), Adrian Haigh (Senior Vice President and General Manager Emea and Asia Pacific Region, PTC Therapeutics) and Alessandra Ferlini (Director of the Medical Genetics Section & Unit, University of Ferrara).
Who sponsors World Orphan Drug Congress 2026?
ConferenceGrid lists 34 sponsors, including Alliance for Regenerative Medicine, Americas Health Foundation, Asebio, Becaris Publishing and BIOCAT.
Company intelligence

What does it mean when 107 companies show up, and 3 bet on three roles at once?

107 companies. three are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
3All threespeak · spons · exh
31Sponsoringsponsor only
1Exhibitingexhibitor only
72Speakingspeaker only

In all three roles

EpiCARE·ERDERA·hollandbio

Speakers by seniority

48% of the speakers carry senior titles: C-suite, Founder, VP, or Director-level.

  • C-suite1315%
  • Founder / Owner22%
  • VP-level78%
  • Director / Head of2023%
  • Manager / Lead1113%
  • Engineer · IC33%
  • Research / Science33%
  • Advisor / Investor67%
  • Other roles2326%

Of 88 speakers · classified by free-text title

Most-represented companies
#CompanyRolesSpeakers
1EpiCARESponsor · Supporting Partner1
2ERDERASponsor · Supporting Partner & Exhibitor1
3hollandbioSponsor · Supporting Partner1
4Alliance for Regenerative MedicineSponsor · Supporting Partner-
5Americas Health FoundationSponsor · Supporting Partner-
6AsebioSponsor · Supporting Partner-
7Becaris PublishingSponsor · Supporting Partner-
8BIOCATSponsor · Supporting Partner-
9BioInsightsSponsor · Supporting Partner-
10Biopharma AsiaSponsor · Supporting Partner-
11Check RareSponsor · Supporting Partner-
12EATRISSponsor · Supporting Partner-
13Endo ERNSponsor · Supporting Partner-
14ERN BONDSponsor · Supporting Partner-
Sponsors by tier
supporting partner30
88% of 34
supporting partner & exhibitor4
12% of 34
At peer events but not here

These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.

Related events · by shared sponsors
ConferenceDateCityShared sponsors
World Vaccine Congress Washington 2027March 9, 2027Washington, D.C.3
Rare Disease Summit 2027March 23, 2027National Harbor3
Biotech ShowcaseJanuary 11, 2027-2